Literature DB >> 20426778

Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis.

E Hagforsen1, H Hedstrand, F Nyberg, G Michaëlsson.   

Abstract

BACKGROUND: Palmoplantar pustulosis (PPP) is a chronic and intensely inflammatory skin disease with pustules, erythema and scaling localized to the palms and soles. To date, no specific treatment is known. Earlier findings indicate the acrosyringium as the target for the inflammation.
OBJECTIVES: To identify specific features of the PPP inflammatory cell infiltrate and mediators of inflammation, which might provide insight into the pathogenesis and possible future treatment of the disease.
METHODS: Skin biopsies were taken from 23 patients with typical PPP (23 from involved skin and seven from noninvolved skin) and from 18 healthy controls (10 nonsmokers, eight smokers). Cell infiltrates and inflammation mediators were studied with immunohistochemistry.
RESULTS: A strong inflammation was observed in lesional skin of PPP. Our main findings of Langerhans cells and interleukin-17 close to or in the acrosyringium differs from findings in psoriasis vulgaris. Other inflammatory cells such as CD4+, CD8+, regulatory T cells and CD11a+ cells were also accumulated close to the sweat duct in epidermis and papillary dermis. More CD4+, CD8+, Langerhans cells, plasmacytoid dendritic cells and a higher proportion of regulatory T cells/CD3+ cells were seen in noninvolved palmar skin from patients with PPP compared with healthy controls.
CONCLUSIONS: Our novel findings indicate that the inflammation in PPP is initiated by the 'stand-by' innate immune system at the acrosyringium.
© 2010 The Authors. Journal Compilation © 2010 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20426778     DOI: 10.1111/j.1365-2133.2010.09819.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

1.  Cutaneous diseases related to a hyperactive T-cell response in ocrelizumab-treated multiple sclerosis patients.

Authors:  Souraya El Sankari; Cyril Van Essche; Vincent van Pesch
Journal:  J Neurol       Date:  2021-06-28       Impact factor: 4.849

2.  Expression of interleukin-17 in lesions of erythema multiforme may indicate a role for T helper 17 cells.

Authors:  Zeynep Meltem Akkurt; Derya Uçmak; Gül Türkcü; Hatice Yüksel; Kenan Yildiz; Mustafa Arıca
Journal:  Cent Eur J Immunol       Date:  2014-10-14       Impact factor: 2.085

3.  Vesicular LL-37 contributes to inflammation of the lesional skin of palmoplantar pustulosis.

Authors:  Masamoto Murakami; Takaaki Kaneko; Teruaki Nakatsuji; Kenji Kameda; Hidenori Okazaki; Xiuju Dai; Yasushi Hanakawa; Mikiko Tohyama; Akemi Ishida-Yamamoto; Koji Sayama
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

4.  Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris.

Authors:  Robert Bissonnette; Mayte Suárez-Fariñas; Xuan Li; Kathleen M Bonifacio; Carrie Brodmerkel; Judilyn Fuentes-Duculan; James G Krueger
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

Review 5.  Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments.

Authors:  Magdalena Misiak-Galazka; Joanna Zozula; Lidia Rudnicka
Journal:  Am J Clin Dermatol       Date:  2020-06       Impact factor: 7.403

6.  Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis.

Authors:  Tae Hyung Kim; Ji Su Kim; Ji Eun Kwon; Bumhee Park; Eun-So Lee
Journal:  Ann Dermatol       Date:  2022-01-27       Impact factor: 1.444

Review 7.  Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.

Authors:  Toshiyuki Yamamoto
Journal:  Clin Pharmacol       Date:  2021-06-23

Review 8.  Pustular psoriasis: pathophysiology and current treatment perspectives.

Authors:  Katie E Benjegerdes; Kimberly Hyde; Dario Kivelevitch; Bobbak Mansouri
Journal:  Psoriasis (Auckl)       Date:  2016-09-12

9.  Successful Treatment of Refractory Palmoplantar Pustular Psoriasis With Apremilast: A Case Series.

Authors:  Sascha Ständer; Felicia Syring; Ralf J Ludwig; Diamant Thaçi
Journal:  Front Med (Lausanne)       Date:  2020-10-15

Review 10.  Pustular Psoriasis: From Pathophysiology to Treatment.

Authors:  Giovanni Genovese; Chiara Moltrasio; Nicoletta Cassano; Carlo Alberto Maronese; Gino Antonio Vena; Angelo Valerio Marzano
Journal:  Biomedicines       Date:  2021-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.